CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Designed for total beginners, this overview covers the basics of Zero Based Budgeting, with simple actions to start budgeting effectively.
19,028 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
CrowdStrike delivered a strong quarter, beating earnings and lifting full-year guidance, and even announced a 4-for-1...
As a rare-earth supplier with the United States' only large-scale mine, MP Materials sits at a pivotal crossroads. If...
Red Cat Holdings faced a sharp price move after news about a government contract came with unclear value. This articl...
Bezos liquidated more than 1.25 million Amazon shares in early May 2026 via prearranged plans as he continues funding...
A June 2026 LISC assessment shows five forces tightening budgets for affordable housing, threatening both new develop...
On a day when the S&P 500 slipped, KLA Corporation stood out. An aggressive price-target upgrade and a scheduled stoc...
A key on-chain signal points to a potential drop toward $700 for ethereum (eth), even as network activity grows and i...
American Water Works raised its quarterly dividend by 8% to $0.895 per share, a move funded by regulator-approved rat...
Former Prime Minister Justin Trudeau has purchased a Montreal mansion for $3.1 million, a move that has investors wat...
Morgan Stanley edges toward its 52-week high as earnings strength and wealth inflows support the rally. Analysts weig...
A sharp drop in Planet Labs shares sparked questions about growth, cash burn, and contract momentum. This guide break...